Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Fundam Clin Pharmacol ; 27(1): 104-12, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21793900

RESUMO

Previous work has shown that intraperitoneal administration of riparin III (ripIII) reduces immobility time in the forced swimming test (FST), which suggests potential antidepressant activity. As the mechanism of action is not completely understood, this study is aimed at investigating the antidepressant-like action of ripIII. Following intraperitoneal administration of ripIII at doses of 25 and 50 mg/kg, there were decreases in the immobility time in the FST and tail suspension test without accompanying changes in ambulation (data not shown). The pretreatment of mice with sulpiride (50 mg/kg, i.p.), prazosin (1 mg/kg, i.p.), yohimbine (1 mg/kg, i.p.), and p-chlorophenylalanine (PCPA, 100 mg/kg, i.p. for, four consecutive days) significantly prevented the anti-immobility effect of ripIII in the FST. On the other hand, the anti-immobility effect of ripIII (50 mg/kg, v.o.) was not altered by pretreatment of mice with SCH23390 (15 µg/kg, i.p.) Furthermore, ripIII potentiated the sleeping latency and sleeping time of the pentobarbital-induced sleeping time test and also potentiated apomorphine (16 mg/kg, i.p.)-induced hypothermia in mice. In conclusion, the present study provides evidence that the antidepressant-like effect of ripIII is dependent on its interaction with the serotonergic, noradrenergic (α1- and α2- receptors), and dopaminergic (dopamine D2 receptors) systems.


Assuntos
Antidepressivos/uso terapêutico , Benzamidas/uso terapêutico , Encéfalo/efeitos dos fármacos , Depressão/tratamento farmacológico , Neurônios/efeitos dos fármacos , Tiramina/análogos & derivados , Administração Oral , Agonistas de Receptores Adrenérgicos alfa 1/administração & dosagem , Agonistas de Receptores Adrenérgicos alfa 1/uso terapêutico , Agonistas de Receptores Adrenérgicos alfa 2/administração & dosagem , Agonistas de Receptores Adrenérgicos alfa 2/uso terapêutico , Animais , Antidepressivos/administração & dosagem , Comportamento Animal/efeitos dos fármacos , Benzamidas/administração & dosagem , Encéfalo/metabolismo , Brasil , Depressão/metabolismo , Agonistas de Dopamina/administração & dosagem , Agonistas de Dopamina/uso terapêutico , Etnofarmacologia , Frutas/química , Frutas/crescimento & desenvolvimento , Guiana , Lauraceae/química , Lauraceae/crescimento & desenvolvimento , Masculino , Camundongos , Neurônios/metabolismo , Receptores de Dopamina D2/agonistas , Receptores de Dopamina D2/metabolismo , Agonistas do Receptor de Serotonina/administração & dosagem , Agonistas do Receptor de Serotonina/uso terapêutico , Tiramina/administração & dosagem , Tiramina/uso terapêutico
2.
J Pharm Pharmacol ; 63(8): 1103-10, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21718294

RESUMO

OBJECTIVES: The antipsychotic, hypnotic, myorelaxant and antioxidant effects of the essential oil of Alpinia zerumbet (EOAZ) were studied. METHODS: EOAZ (50, 100 and 200 mg/kg i.p.) was administered once to mice for the determination of antipsychotic activity (evaluated by ketamine-induced hyperlocomotion), hypnotic activity (induced by sodium pentobarbital, 40 mg/kg i.p.), motor coordination (rotarod test), antioxidant effects (determination of lipid peroxidation and GSH levels), as well as alterations in nitric oxide levels (determination of nitrite content). KEY FINDINGS: EOAZ at doses of 100 and 200 mg/kg prevented ketamine hyperlocomotion, as did haloperidol (0.2 mg/kg i.p). EOAZ at a dose of 200 mg/kg decreased sleep latency, while all doses increased sleeping time. There was no effect on motor coordination. The in-vitro antioxidant capacity of the oil caused a decrease in lipid peroxidation and increase in GSH levels. EOAZ also prevented the decrease in nitrite content caused by oxidative stress. CONCLUSIONS: The results suggest antipsychotic and antioxidant effects for the EOAZ that may have promising efficacy for the treatment of schizophrenia.


Assuntos
Alpinia/química , Antioxidantes/farmacologia , Antipsicóticos/farmacologia , Hipnóticos e Sedativos/farmacologia , Locomoção/efeitos dos fármacos , Óleos Voláteis/farmacologia , Esquizofrenia/fisiopatologia , Animais , Antioxidantes/uso terapêutico , Antipsicóticos/uso terapêutico , Glutationa/metabolismo , Haloperidol/farmacologia , Haloperidol/uso terapêutico , Hipnóticos e Sedativos/uso terapêutico , Ketamina , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Camundongos , Atividade Motora/efeitos dos fármacos , Nitritos/metabolismo , Óleos Voláteis/uso terapêutico , Estresse Oxidativo/efeitos dos fármacos , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Folhas de Planta , Esquizofrenia/tratamento farmacológico , Esquizofrenia/metabolismo , Sono/efeitos dos fármacos
3.
J Pharm Pharmacol ; 61(11): 1521-7, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19903378

RESUMO

OBJECTIVES: Alpinia zerumbet, known in Brazil as colônia, is popularly used as a diuretic, antihypertensive, anti-ulcerogenic and sedative. Based on this, we have investigated the central effects of the essential oil isolated from A. zerumbet leaves. METHODS: Mice were treated once with 50 or 100 mg/kg of the essential oil, intraperitoneally, 30 min before being submitted to behavioural models of: locomotor activity (open-field), catalepsy, anxiety (elevated plus maze), depression (forced swimming test and tail suspension tests) as well as apomorphine-induced stereotypy. KEY FINDINGS: Results showed a dose-related decrease on locomotor activity and apomorphine-induced stereotypy. There was a decrease to the order of 55% of the grooming behaviour with both doses studied. The essential oil 100 mg/kg increased cataleptic activity (167%) and the immobility time in the forced swimming and tail suspension tests. Pretreatment with haloperidol (0.2 mg/kg, i.p.) alone also decreased locomotion, increased cataleptic activity and immobility time in the tail suspension test. No alterations in the elevated plus maze test were registered. CONCLUSIONS: The essential oil of A. zerumbet leaves had depressant and possible antipsychotic activity, since it could reverse the stereotypy induced by apomorphine, presenting effects comparable with those obtained with haloperidol treatment.


Assuntos
Alpinia/química , Comportamento Animal/efeitos dos fármacos , Sistema Nervoso Central/efeitos dos fármacos , Atividade Motora/efeitos dos fármacos , Óleos Voláteis/farmacologia , Extratos Vegetais/farmacologia , Animais , Antipsicóticos/farmacologia , Ansiedade , Apomorfina , Catalepsia , Depressores do Sistema Nervoso Central/farmacologia , Antagonistas de Dopamina/farmacologia , Relação Dose-Resposta a Droga , Haloperidol/farmacologia , Aprendizagem em Labirinto , Camundongos , Óleos Voláteis/administração & dosagem , Óleos Voláteis/química , Extratos Vegetais/administração & dosagem , Extratos Vegetais/química , Cauda
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA